Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.
- Revenue: $77.17M. Running result $77.17M. Central Laboratory Business: $22.88M. Inhospital Business: $32.04M. Pharma Research And Development Services: $22.25M.
- Cost of revenue: −$19.54M. Running result $57.63M.
- Gross profit: $57.63M. Running result $57.63M.
- Operating costs: −$65.47M. Running result −$7.84M.
- Operating income: −$7.84M. Running result −$7.84M.
- Other income: $150.89K. Running result −$7.69M.
- Pre-tax loss: −$7.69M. Running result −$7.69M.
- Income tax expense: −$222.54K. Running result −$7.92M.
- Net loss: −$7.92M. Running result −$7.92M.
